Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus XR vs IR Tacrolimus in Lung Transplant
NCT04420195Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Oct 2020
- Primary completion
- Nov 2022
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus in lung transplant rejection, sponsored by NYU Langone Health. Started Oct 2020; status: completed.
02
Drugs
tacrolimus
03
Conditions
lung transplant rejection
Beyond the preview
Go deeper on NCT04420195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04420195.